Estazolam
| Estazolam | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 294.74 g/mol [1] |
| Melting point | 228-229 [1] |
| Solubility | Practically insoluble (1.5 mg/L) [1] |
| Predicted LogP | 1.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H11ClN4 |
| IUPAC name | 8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine |
| SMILES | C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4 |
| InChI | InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2 |
| InChIKey | CDCHDCWJMGXXRH-UHFFFAOYSA-N |
| CAS number | 29975-16-4 |
| UNII | 36S3EQV54C |
| PubChem CID | 3261 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 10–24 hours |
| Metabolism | Liver |
| Excretion | Kidney |
| Routes of administration | By mouth |
| Toxicity [] | |
|---|---|
| LD50 | Male Mice: - oral: 740 mg/kg [1] |
Estazolam (also known as Eurodin, ProSom, Esilgan, D 40ta, Estazolamum, Abbott-47631, Estazolam civ, 8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine, 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl- or 8-Chloro-6-phenyl-4H-(1,2,4)triazolo-(4,3-a)(1,4)benzodiazepine) is a substance of the triazolobenzodiazepine class.
Chemistry
Stereochemistry []
Estazolam is achiral.
Druglikeness
Lipinski's rule of five
Estazolam matches Lipinski's rule of five.Reagents
There are currently 3 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | no color change |
Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- hypnotics and sedatives (N05C)
- benzodiazepine derivatives (N05CD)
- estazolam (N05CD04)
MeSH Classification
Mechanism of action []
Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABA<sub>A</sub>) receptors, this enhances the effects GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| CYP3A | inhibition / metabolism / induction | 52 (3 contraindicated) |
|---|---|---|
| GABRA1 | shared target | 9 |
| GABRA2 | shared target | 9 |
| GABRA3 | shared target | 9 |
| GABRA4 | shared target | 9 |
| GABRA5 | shared target | 9 |
| GABRA6 | shared target | 9 |
| GABRB1 | shared target | 9 |
| GABRB2 | shared target | 9 |
| GABRB3 | shared target | 9 |
| GABRD | shared target | 9 |
| GABRE | shared target | 9 |
| GABRG1 | shared target | 9 |
| GABRG2 | shared target | 9 |
| GABRG3 | shared target | 9 |
| GABRP | shared target | 9 |
| GABRQ | shared target | 9 |
Medical side effects []
130 side effects listed on drug labels in SIDER 4.1 (estazolam).
- Somnolence
- Headache
- Asthenia
- Nervousness
- Tension
- Hypokinesia
- Dizziness
- Syncope
- Anxiety
- Constipation
- Dry mouth
- Malaise
- Discomfort
- Feeling abnormal
- Confusional state
- Ill-defined disorder
- Nausea
- Coordination abnormal
- Hangover
- Pain in extremity
- Pain in arm
- Nasopharyngitis
- Back pain
- Depression
- Dyspepsia
- Pain
- Thinking abnormal
- Mental disability
- Abdominal pain
- Gastrointestinal pain
- Chest pain
- Pharyngitis
- Musculoskeletal stiffness
- Pruritus
- Amnesia
- Arthritis
- Asthma
- Neck pain
- Cough
- Dysmenorrhoea
- Dyspnoea
- Ear pain
- Dermatitis
- Rash
- Body temperature increased
- Flatulence
- Flushing
- Gastritis
- Hostility
- Hypersensitivity
- Palpitations
- Paraesthesia
- Rhinitis
- Convulsion
- Sinusitis
- Muscle spasms
- Hyperhidrosis
- Thirst
- Tinnitus
- Pollakiuria
- Micturition urgency
- Urticaria
- Vomiting
- Chills
- Stupor
- Depressed level of consciousness
- Agitation
- Apathy
- Flat affect
- Mood swings
- Affect lability
- Photophobia
- Eye pain
- Urinary hesitation
- Vaginal discharge
- Myalgia
- Musculoskeletal discomfort
- Arthralgia
- Muscle twitching
- Increased appetite
- Decreased appetite
- Euphoric mood
- Eye irritation
- Eye swelling
- Sleep disorder
- Visual impairment
- Arrhythmia
- Ataxia
- Breast swelling
- Libido decreased
- Disturbance in sexual arousal
- Diplopia
- Oedema
- Enterocolitis
- Epistaxis
- Hallucination
- Hearing impaired
- Haematuria
- Hyperventilation
- Laryngitis
- Leukopenia
- Melaena
- Neuritis
- Neuropathy peripheral
- Nocturia
- Nystagmus
- Oliguria
- Purpura
- Vascular purpura
- Scotoma
- Shock
- Loss of consciousness
- Thyroid neoplasm
- Tremor
- Ulcer
- Urinary incontinence
- Weight increased
- Weight decreased
- Paraesthesia oral
- Hyporeflexia
- Aspartate aminotransferase increased
- Dry skin
- Penile discharge
- Pain in jaw
- Lymphadenopathy
- Agranulocytosis
- Erythema multiforme
- Stevens-Johnson syndrome
- Malnutrition
- Photosensitivity reaction
Indications
- Insomnia
Legal status []
- Brazil: Estazolam is a B1.[3]
- Canada: Estazolam is a Schedule IV.
- Germany: Estazolam is Prescription only/Anlage III.
- United Kingdom: Estazolam is a Class C under the "Misuse of Drugs Act 1971".
- United States: Estazolam is a Schedule IV under the "Controlled Substances Act".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3261, Estazolam. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3261
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Estazolam. UNII: 36S3EQV54C. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/36S3EQV54C
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:00:13 |
| drugspro | ok | 2026-11-20 18:00:09 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 18:00:09 |
| gsrs | ok | 2026-11-20 18:00:09 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015346) | 2026-11-20 18:00:09 |
| kegg | ok | 2026-11-20 18:00:11 |
| pubchem | ok | 2026-11-20 18:00:08 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:00:09 | |
| sider | ok | 2026-11-20 18:00:09 |
| structure | ok | 2026-11-20 18:00:09 |
| wikipedia | ok | 2026-11-20 18:00:09 |